Navigation Links
Isis Pharmaceuticals to Present a General Corporate Update at its 2013 Annual Meeting of Stockholders and Open House
Date:6/18/2013

CARLSBAD, Calif., June 18, 2013 /PRNewswire/ -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), the leader in antisense therapeutics, today announced that management will present a general corporate update in conjunction with its 2013 Annual Meeting of Stockholders and Open House on Tuesday, June 25 at 2:10 p.m. Pacific Time in Carlsbad, CA.

The agenda for the meeting is as follows:
2:00 p.m. – 2:10 p.m. Annual Meeting of Stockholders (only for stockholders of record as of April 26, 2013)
2:10 p.m. – 3:15 p.m. Corporate Presentation – Stanley T. Crooke, Isis' Chairman and Chief Executive Officer
3:15 p.m. – 5:00 p.m. Scientific Poster Presentation and Open House

A live audio webcast of the presentation will be available on the "Investors & Media" section of the Company's Web site, www.isispharm.com. A replay of the presentation will be available on the Isis Web site within 48 hours and will be archived for a limited time. 

To RSVP to attend the meeting, please go to Isis' Home Page at www.isispharm.com.

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 28 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH.  Genzyme is also pursuing marketing approval of KYNAMRO in other markets.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.


'/>"/>
SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2017)... WHIPPANY, N.J. , July 11, 2017  Bayer has ... across eight countries as part of its prestigious Bayer Hemophilia ... Children,s Hospital of Philadelphia and Uniformed ... are among the winners. Grant recipients were announced ... Thrombosis and Hemostasis (ISTH) 2017 Congress, Berlin, Germany ...
(Date:7/11/2017)... JERUSALEM , July 11, 2017 Oramed ... ), a clinical-stage pharmaceutical company focused on the development ... U.S. Food and Drug Administration (FDA) has agreed to ... successfully completed Phase IIb trial of its oral insulin ... The Phase IIb trial met primary and secondary endpoints ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
Breaking Medicine Technology:
(Date:7/21/2017)... ... July 21, 2017 , ... Roderick Crabbe Insurance, a Jacksonville ... and business owners in northern Florida, is joining the First Coast chapter of ... adults with developmental challenges. , The First Coast YMCA offers assistance to parents ...
(Date:7/21/2017)... ... 21, 2017 , ... Adolfson & Peterson Construction (AP) along ... County Medical Examiners Facility located in Saint Paul, Minn. A single story, 10,688 ... to start in late 2017/early 2018. , Staffed by 20 full-time employees ...
(Date:7/21/2017)... ... , ... Thomas Jefferson University , in collaboration with ... $300,000 grant from The Pew Center for Arts & Heritage to build on ... of one’s own limits among health professions students. , The two-year project ...
(Date:7/21/2017)... ONTARIO, CANADA (PRWEB) , ... July 21, 2017 , ... ... IL and Past President of the American Orthopaedic Society of Sports Medicine (AOSSM) ... 21, 2017 during the AOSSM Annual Meeting in Toronto, Canada. This prestigious award is ...
(Date:7/21/2017)... ... ... and Overseer at The House of Yahweh in Abilene, Texas, has written a new post ... with world leaders to be more open about positive changes. Yisrayl says the use of ... a peaceful and positive way to solve all; yes, all issues, and he is ready ...
Breaking Medicine News(10 mins):